secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2023-11-27T23:59:59+00:00
Accession:  0001683168-23-008454
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dr. Charles Fisher resigns from Aethlon board Nov 27; $460k severance, 50% option acceleration
--------------------------------------------------------------------------------

- Dr. Charles J. Fisher, Jr. resigns as director effective Nov 27, 2023; previously stepped down as CEO Nov 7.
- Severance includes 12 months base salary ($460,000 total), paid over regular payroll schedule.
- 50% of outstanding unvested time-based stock options will accelerate and become fully vested.
- COBRA healthcare premium reimbursement provided for up to 12 months post separation.
- James B. Frakes, previously appointed Interim CEO, remains as interim CEO and CFO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316823008454/0001683168-23-008454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316823008454/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-008454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer